Buy Tirzepatide Starter Kit in Australia
Buy the Tirzepatide starter kit in Australia from Macropus Peptides: one 20mg vial of research-grade Tirzepatide as lyophilised powder, a 3 mL vial of bacteriostatic water, ten 0.5 mL insulin syringes and twenty alcohol swabs. Tirzepatide is a 39 amino acid peptide that activates both the GIP and GLP-1 receptors, carrying a fatty diacid chain that binds albumin. The 20mg fill is our priced strength, and the kit costs less than the vial, water, syringe pack and swab pack ordered as separate lines. Each vial is labelled with its lot number, and the certificate of analysis for that lot is available on request. Order online and the kit is dispatched from Australian stock to every Australian state and territory. This is research material only, sold to adults for in-vitro laboratory work, not for human or veterinary use.
| Kit | Tirzepatide starter kit |
|---|---|
| Amount | starter kit |
| Form | Research kit |
| Contents | Tirzepatide 20mg vial, BAC water 3 mL, 10 × 0.5 mL insulin syringes and 20 alcohol swabs |
| Category | Kits, stacks and value packs |
| Storage | See label |
| Testing | HPLC purity and mass spectrometry identity, every batch |
| Certificate of analysis | Available for every lot, matched to the lot number on the label |
Buy Tirzepatide Starter Kit Australia: 20mg Vial and Supplies
Twenty milligrams is a large fill for an incretin peptide, and it makes a strong stock in a small volume. The kit pairs that vial with a 3 mL diluent and handling supplies so the first reconstitution needs nothing else.
Tirzepatide: a dual incretin receptor agonist
The gut releases two incretin hormones after a meal, GIP and GLP-1, which act on separate receptors to raise insulin release when glucose is high. Tirzepatide is a single 39 residue peptide, built mainly on the GIP sequence, that activates both. It includes non-natural amino acids to resist enzymatic breakdown and a C20 fatty diacid chain that binds albumin, which extends its half-life to several days. Laboratories use it to compare dual agonism with GLP-1 alone and with triple agonists. More detail is on the Tirzepatide vial listing.
Tirzepatide research record
Its discovery and first clinical data, under the code LY3298176, were published in Molecular Metabolism in 2018. The New England Journal of Medicine then reported a head-to-head trial against a GLP-1 agonist in type 2 diabetes in 2021, and a 72-week trial in adults with obesity in 2022 that measured body weight change. Those trials make it one of the most documented peptides in metabolic science.
Tirzepatide kit specifications per order
| Specification | Detail |
|---|---|
| Kit | Tirzepatide starter kit |
| Amount | starter kit |
| Form | Research kit |
| Contents | Tirzepatide 20mg vial, BAC water 3 mL, 10 × 0.5 mL insulin syringes and 20 alcohol swabs |
| Category | Kits, stacks and value packs |
| Storage | See label |
- 20mg Tirzepatide as freeze-dried powder, lot and freezer temperature printed on the vial
- 3 mL of bacteriostatic water
- 10 insulin syringes, 0.5 mL capacity
- 20 alcohol swabs
Reconstituting Tirzepatide 20mg
Two millilitres of water makes 10 mg per mL. A 2.5 mL volume makes 8 mg per mL, and the whole 3 mL makes about 6.67 mg per mL. Measured on the kit syringes, half a millilitre is split into fifty equal marks of 0.01 mL. Additional bacteriostatic water 10mL can go in the same parcel.
Tirzepatide price: kit compared with the parts
| Option | Price |
|---|---|
| Tirzepatide starter kit | $262.99 |
Four separate lines, the 20mg vial, one water bottle, the smallest syringe box and a swab tub, total more than this kit. Dual agonist plus diluent on their own already match the kit price almost to the cent, so syringes and swabs arrive at no real cost.
Tirzepatide 20mg storage after purchase
Lipidated peptides are stable dry. Hold the 20mg vial at -20 °C inside its carton. Once dissolved, keep the dual agonist refrigerated (2 to 8 °C) and never refreeze the stock.
Is Tirzepatide available in Australia
Finished medicines containing it are entered on the ARTG by their sponsor and sit in Schedule 4 of the Poisons Standard. Our 20mg vial is none of those: it is unregistered laboratory material, supplied for in-vitro work alone and never for human or veterinary use.
Tirzepatide for sale Australia wide
Dual agonist kits travel from our Australian shelves to city and country addresses in every state. Metabolic groups weigh it against the triple agonist in the Retatrutide starter kit or the amylin analogue in the Cagrilintide starter kit, or browse kits and stacks.
References
- LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept. Molecular Metabolism. 2018.
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine. 2021.
- Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
Scientific content compiled from the peer-reviewed literature above by the Macropus Peptides technical team. Information is provided for research reference only.